RecruitingPhase 2NCT06226883A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseSponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Fayetteville, NC · High Point, NC · Raleigh, NC · +22 more sites
RecruitingPhase 3NCT06819891A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseSponsor: Hoffmann-La RocheCharlotte, NC · High Point, NC · +59 more sites
RecruitingPhase 2NCT07113522A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseaseSponsor: Mirador Therapeutics, Inc.High Point, NC · Raleigh, NC · +44 more sites